B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 5928-5935

  Hori, Junko ^a   Wang, Mingcong ^a   Miyashita, Megumi ^a   Tanemoto, Keiko ^a   Takahashi, Hiroshi ^a   Takemori, Toshitada ^b   Okumura, Ko ^c   Yagita, Hideo ^c   Azuma, Miyuki ^d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B7 ANTIGEN; B7 DC ANTIGEN; B7 H1 ANTIGEN; CD4 ANTIGEN; PROGRAMMED DEATH LIGAND 1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CILIARY BODY; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; EFFECTOR CELL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IRIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA;

EID: 33750350800     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.5928     Document Type: Article

References (56)

1. Boisjoly, H. M., R. Tourigny, R. Bazin, P. A. Laughrea, I. Dube, G. Chamberland, J. Bernier, and R. Roy. 1993. Risk factors of corneal graft failure. Ophthalmology 100: 1728-1735.
2. Williams, K. A., D. Roder, A. Esterman, S. M. Muehlberg, and D. J. Coster. 1992. Factors predictive of corneal graft survival: report from the Australian corneal graft registry. Ophthalmology 99: 403-414.
3. Wilson, S. E., and H. E. Kaufman. 1990. Graft failure after penetrating keratoplasty. Surv. Ophthalmol. 34: 325-356.
4. Sonoda, Y., and J. W. Streilein. 1992. Orthotopic corneal transplantation in mice-evidence that the immunogeneic rules of rejection do not apply. Transplantation 54: 694-704.
5. Williams, K. A., and D. J. Coster. 1985. Penetrating corneal transplantation in the inbred rat: a new model. Invest. Ophthalmol. Vis. Sci. 26: 23-30.
6. Sonoda, Y., and J. W. Streilein. 1993. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allograft. J. Immunol. 150: 1727-1734.
7. Streilein, J. W. 1987. Immune regulation and the eye: a dangerous compromise. FASEB J. 1: 199-208.
8. Niederkorn, J. Y. 1990. Immune privilege and immune regulation in the eye. Adv. Immunol. 48: 191-226.
9. 1 lymphocyte-induced immune deviation. J. Immunol. 118: 809-814.
10. Streilein, J. W. 2003. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3: 879-889.
11. Namba, K., N. Kitaichi, T. Nishida, and A. W. Taylor. 2002. Identification α-melanocyte stimulating hormone and transforming growth factor-β2. J. Leukocyte Biol. 72: 946-952.
12. Kaiser, C. J., B. R. Ksander, and J. W. Streilein. 1989. Inhibition of lymphocyte proliferation by aqueous humor. Reg. Immunol. 2: 42-49.
13. Taylor, A. W., D. O. Yee, and J. W. Streilein. 1998. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest. Ophthalmol. Vis. Sci. 39: 1372-1378.
14. Willbanks, G. A., M. M. Mammolenti, and J. W. Streilein. 1992. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22: 165-173.
15. Sheibani, N., C. M. Sorenson, L. A. Cornelius, and W. A. Frazier. 2000. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem. Biophys. Res. Commun. 267: 257-268.
16. Apte, R. S., D. Sinha, E. Mayhew, G. L. Wistow, and J. Y. Niederkorn. 1998. Role of macrophage migration inhibitory factor in inhibition NK cell activity. J. Immunol. 160: 5693-5696.
17. Kennedy, M. C., J. T. Rosenbaum, and J. Brown. 1995. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J. Clin. Invest. 95: 82-88.
18. Shon, J. H., H. J. Kaplan, H. J. Suk, P. S. Bora, and N. S. Bora. 2000. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest. Ophthalmol. Vis. Sci. 41: 4195-4202.
19. Sugita, S. C. Taguchi, H. Takase, K. Sagawa, J. Sueda, K. Fukushi, N. Hikita, T. Watanabe, K. Itoh, and M. Mochizuki. 2000. Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis. Br. J. Ophthalmol. 84: 1130-1134.
20. Medawar, P. B. 1948. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Path. 29: 58-69.
21. Barker, C. F., and R. E. Billingham. 1977. Immunologically privileged sites. Adv. Immunol. 25: 1-54.
22. Streilein, J. W., G. B. Toews, and P. R. Bergstresser. 1979. Corneal allografts fail to express Ia antigens. Nature 282: 326-327.
23. + corneal stromal cells are bone, marrow-derived and express hemopoietic stem cells markers. Stem Cells 23: 507-515.
24. Hamrah, P., Q. Zhang, Y. Liu, and M. R. Dana. 2002. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest. Ophthalmol. Vis. Sci. 43: 639-646.
25. Whitsett, C. F., and R. D. Stulting. 1984. The distribution of HLA antigens on human corneal tissue. Invest. Ophthalmol. Vis. Sci. 25: 519-524.
26. Wang, H. M., H. J. Kaplan, W. C. Chan, and M. Johnson. 1987. The distribution and ontogeny of MHC antigens in murine ocular tissue. Invest. Ophthalmol. Vis. Sci. 28: 1383-1389.
27. Treseler, P. A., and F. Sanfilippo. 1986. The expression of major histocompatibility complex and leukocyte antigens by cells in the rat cornea. Transplantation 41: 248-252.
28. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. 1995. FAS ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192.
29. Stuart, P. M., T. S. Griffith, N. Usui, J. Pepose, X. Yu, and T. A. Ferguson. 1997. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest. 99: 396-402.
30. Hori, J., N. Joyce, and J. W. Streilein. 2000. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule. Invest. Ophthalmol. Vis. Sci. 41: 443-452.
31. Hori, J., N. C. Joyce, and Streilein, J. W. 2000. Immune privilege and immunogenicity reside among layers of the mouse cornea. Invest. Ophthalmol. Vis. Sci. 41: 3032-3042.
32. Ishida, Y., T. Agata, K. Shibahara, and T. Honjo. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11: 3887-3895.
33. Nishimura, H., M. Nose, H. Hirai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding and ITIM motif-carrying immunoreceptor. Immunity 11: 141-151.
34. Sharpe, A. H., and G. J. Freeman. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2: 116-126.
35. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5: 1365-1369.
36. Tseng, S. Y., M. Otsuji, K. Gorski, X. Huang, J. E. Slansky, S. I. Pai, A. Shalabi, T. Shin, D. M. Pardoll, and T. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193: 839-846.
37. Freeman, G. J., Y. Long, Y. Iwai, K. Bourque, T. Chenova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192: 1027-1034.
38. Latchman, Y., C. R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2: 261-268.
39. Yamazaki, T., H. Akiba, H., H. Iwai, H. Matsuda, M. Aoki, Y. Tanno, T. Shin, H. Tsuchiya, D. M. Pardoll, K. Okumura, et al. 2002. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169: 5538-5545.
40. Dong, H., S. E. Strome, D. R. Salomao, H. Tamura, F. Hirano, D. B. Flies, P. C. Roche, J. Lu, G. Zhu, K. Tamada, et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8: 793-800.
41. Tsushima, F., H. Iwai, N. Otsuki, M. Abe, S. Hirose, T. Yamazaki, H. Akiba, H. Yagita, Y. Takahashi, K. Okumura, and M. Azuma. 2003. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur. J. Immunol. 33: 2773-2782.
42. + T cell proliferation by augmenting IFN-γ-induced nitric oxide production. J. Immunol. 175: 1586-1592.
43. Hori, J., and J. W. Streilein. 2001. Role of recipient epithelium in promoting survival of orthotopic corneal allograft in mice. Invest. Ophthalmol. Vis. Sci. 42: 720-726.
44. Kawashima, H., S. Yamagami, T. Tsuru, and D. S. Gregerson. 1997. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation. Eur. J. Immunol. 27: 2490-2494.
45. Hori, J., and J. W. Streilein. 2001. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest. Ophthalmol. Vis. Sci. 42: 1820-1828.
46. + T lymphocytes. Immunity 20: 327-336.
47. Yu, M. C., H. C. Chen, X. Liang, L. Wang, C. R. Gandhi, J. J. Fung, L. Lu, and S. Qian. 2004. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40: 1312-1321.
48. Nishimura, H., T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hirai, N. Minato, and T. Honjo. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319-322.
49. Salama, A. D., T. Chitnis, J. Imitola, M. J. Ansari, H. Akiba, F. Tsushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury. 2003. Critical role of programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198: 71-78.
50. Ansari, M. J., A. D. Salama, T. Chitnis, R. N. Smith, H. Yagita, H. Akiba, T. Yamazaki, M. Azuma, H. Iwai, S. J. Khoury, et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198: 63-69.
51. Tamura, H., H. Dong, G. Zhu, G. L. Sica, D. B. Files, K. Tamada, and L. Chen. 2001. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 97: 1809-1816.
52. Kanai, T., T. Totsuka, K. Uraushihara, S. Makita, T. Nakamura, K. Koganei, T. Fukushima, H. Akiba, H. Yagita, and K. Okumura. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171: 4156-4163.
53. Subudhi, S. K., P. Zhou, L. M. Yerian, R. K. Chin, J. C. Lo, R. A. Anders, Y. Sun, L. Chen, Y. Wang, M. L. Alegre, and Y. X. Fu. 2004. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113: 694-700.
54. Freeman, G. J., A. H. Sharpe, and V. K. Kuchroo. 2002. Protect the killer: CTLs need defenses against the tumor. Nat. Med. 8: 787-789.
55. Niederkorn, J. Y., E. Y. Chiang, T. Ungchusri, and I. Stroynowski. 1999. Expression of a nonclassical MHC class 1b molecule in the eye. Transplantation 68: 1790-1799.
56. Bora, N. S., C. I. Gobleman, J. P. Atkinson, J. S. Pepose, and H. J. Kaplan. 1993. Differential expression of the complement regulatory proteins in the human eye. Invest. Ophthalmol. Vis. Sci. 34: 3579-3584.